Navigation Links
Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
Date:11/29/2007

Neptune Technologies & Bioressources Inc. and Salt Lake City based Schiff Nutrition International, Inc. entered into a distribution agreement for U.S. nationwide distribution of Neptune Krill Oil under the brand name

Schiff(R) MegaRed(TM)

LAVAL, QC, Nov. 29 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB) is pleased to announce that it has entered into a distribution agreement with Schiff Nutrition International, Inc. for the distribution of Neptune Krill Oil under the brand name Schiff(R) MegaRed(TM). Schiff(R) MegaRed(TM) is expected to become available in the consumer mass market in the United States with an initial product launch through Costco planned for January 2008.

Schiff(R) MegaRed(TM) contains Neptune Krill Oil, NKO(R), a marine oil extracted from Antarctic Krill, patented for its extraction process, natural and synthetic composition, and for its use as a medication or cosmeceutical. NKO(R) safety and health benefits have been demonstrated by clinical studies. The results of a clinical study on hyperlipidemia (high cholesterol) have shown that NKO(R) may reduce total cholesterol levels, LDL (bad cholesterol) and triglycerides, while increasing HDL (good cholesterol). Another clinical study has shown that NKO(R) can significantly reduce an inflammation biomarker (CRP) and can improve arthritic symptoms. In order to satisfy the continuously increasing public demand for safe and effective natural products for cardiovascular health, Neptune and Schiff Nutrition have joined efforts to make Schiff(R) MegaRed(TM) readily accessible to the consumer.

"In line with the company's corporate strategy, Neptune is penetrating the U.S. dietary supplement mass market in collaboration with Schiff Nutrition, a leader in its field, recognized for its longstanding consumer marketing capabilities. As planned, Neptune is increasing consumer awareness and access to NKO(R) through one of the world's largest retailers, Costco," stated Thierry Houillon, Vice-President, Nutraceutical of Neptune. "Schiff Nutrition's track record and experience in the $22 billion(x) U.S. dietary supplement market will ensure that a broader portion of the population will now benefit from our product. Costco operates in 385 U.S. locations and reported total annual revenues beyond $60 billion and 50.4 million cardholders. Entering alliances that leverage each partner's marketing and commercialization network, strength and expertise is part of Neptune's business strategy," he added.

About Neptune Technologies & Bioressources Inc.

Neptune develops proprietary health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using its proprietary process, the Company is strategically positioning itself in the health and wellness market.

Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.

Neptune continues to strongly support its strategic development plan to form partnerships/strategic alliances with worldwide leaders in the nutraceutical and pharmaceutical industries. Neptune has recently signed agreements with Nestle and Yoplait, worldwide leading food manufacturers, paving its entrance into the global functional food market. According to its business strategy, negotiations with pharmaceutical companies with the objective of entering the pharmaceutical market by licensing rights are ongoing.

NASDAQ and TSX venture exchange does not accept responsibility for the

adequacy or accuracy of this press release.

(x) Business Insights Ltd, 2007

Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission.


'/>"/>
SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
2. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
3. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
Breaking Biology Technology:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):